Related Experiment Video
Updated: Jun 27, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Off-pump coronary artery bypass grafting in patient with Sheehan's syndrome
Qiang Fu1, Hao Zhang, Min Peng
1Department of Cardiovascular Surgery, Tianjin Medical University General Hospital, Tianjin, PR China.
Insights
Patients with Sheehan's syndrome and angina can safely undergo off-pump coronary artery bypass grafting. Careful hormonal management, including hydrocortisone and thyroxine, is crucial for successful outcomes in hypopituitarism patients.
Area of Science:
- Cardiovascular Surgery
- Endocrinology
- Cardiology
Background:
- Sheehan's syndrome, a cause of hypopituitarism, presents unique challenges for surgical patients.
- Coronary artery disease, such as angina pectoris, necessitates surgical intervention.
- Off-pump coronary artery bypass grafting (OPCAB) is a surgical technique that avoids cardiopulmonary bypass.
Observation:
- A patient diagnosed with angina pectoris and Sheehan's syndrome underwent OPCAB.
- Perioperative management included hydrocortisone and oral thyroxine replacement.
- The patient experienced no significant postoperative complications.
Findings:
- Hormonal management with hydrocortisone and thyroxine was effective during OPCAB.
- OPCAB is a viable and safe option for patients with hypopituitarism.
- Successful surgical outcomes are achievable with meticulous perioperative endocrine support.
Implications:
- This case highlights the safety and necessity of careful hormonal management in hypopituitary patients undergoing cardiac surgery.
- Endocrinological and surgical teams must collaborate for optimal patient care.
- Further studies may explore broader applications of OPCAB in patients with complex endocrine disorders.
Abstract:
A patient with angina pectoris and Sheehan's syndrome underwent off-pump coronary bypass grafting. Perioperative hydrocortisone and oral thyroxin replacement were used, and no relative complication was found postoperatively. Careful perioperative hormonal management is necessary and safe for patients with hypopituitarism to receive off-pump coronary artery bypass grafting.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
Published on: April 24, 2017